{
    "title": "Alnylam's gene-silencing drug cuts blood pressure in mid-stage trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12491597/Alnylam-hypertension-drug-meets-main-goal-mid-stage-study.html",
    "date": "2023-09-07",
    "keywords": [
        "blood",
        "pressure",
        "therapy",
        "trial",
        "zilebesiran",
        "hypertension",
        "heart",
        "month",
        "study",
        "thursday",
        "genesilencing",
        "midstage",
        "mercury",
        "period",
        "illness",
        "risk",
        "benefit",
        "order",
        "market",
        "potential",
        "field",
        "medicine",
        "innovation",
        "program",
        "lead",
        "development",
        "placebo",
        "improvement",
        "alnylam",
        "company",
        "july",
        "partnership",
        "roche",
        "giant",
        "commercialization",
        "country",
        "payment",
        "drug",
        "companys",
        "rna",
        "interference",
        "technology",
        "disease",
        "reporting",
        "leo",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}